Press Releases | DEA.gov
Pasar al contenido principal
U.S. flag

Un sitio oficial del Gobierno de Estados Unidos

Así es como usted puede verificarlo

Dot gov
Los sitios web oficiales usan .gov
Un sitio web .gov pertenece a una organización oficial del Gobierno de Estados Unidos.
Https

Los sitios web seguros .gov usan HTTPS
Un candado ( Candado Un candado cerrado ) o https:// significa que usted se conectó de forma segura a un sitio web .gov. Comparta información sensible sólo en sitios web oficiales y seguros.

  • Quiénes somos
    • Sobre la DEA
    • Mission
    • Leadership
    • Nuestra historia
    • Divisiones Nacionales
      • Operational Divisions
    • DEA Museum
    • Wall of Honor
    • Contáctenos
      • Submit a Tip
      • Extortion Scam
      • Public Affairs
      • Social Media Directory
  • Recursos
    • Cartels
    • Illegal Online Pharmacies
    • OD Justice
    • Fentanyl Supply Chain
    • Pill Press Resources
    • Recovery Resources
    • Together for Families
    • Ley de Libertad de Información
      • Fee Waiver
    • Publications
    • Galerías Multimedia
    • Programa de Asistencia a Testigos para Víctimas
      • Human Trafficking Prevention

United States Drug Enforcement Administration

  • Recibir Actualizaciones
  • Scam Alert
  • Menú Completo
  • English
  • Español

Main Menu

Explore DEA
  • Quiénes somos
    • Sobre la DEA
    • Mission
    • Leadership
    • Nuestra historia
    • Divisiones Nacionales
    • DEA Museum
    • Wall of Honor
    • Contáctenos
  • Recursos
    • Cartels
    • Illegal Online Pharmacies
    • OD Justice
    • Fentanyl Supply Chain
    • Pill Press Resources
    • Recovery Resources
    • Together for Families
    • Ley de Libertad de Información
    • Publications
    • Galerías Multimedia
    • Programa de Asistencia a Testigos para Víctimas

Press Releases

Advanced Search

Enter Keywords Below

Filter Results

Select To Narrow Search Results

Year

  • 2024 (2)
  • 2023 (3)
  • 2022 (3)
  • 2021 (5)
  • 2020 (3)

Subject

  • Pharmaceuticals/Pharmacists/Physicians (8)
  • Prescription Drugs (8)
  • Diversion Division (5)
  • Drug Trafficking (3)
  • Arrests/Convictions - Major (1)
  • Guns/Weapons (1)
  • Major Law Enforcement Operation (1)
  • OCDETF/Task Force (1)
  • Outreach/Drug Prevention (1)

Drug Name

  • Methamphetamine (351)
  • Cocaine (262)
  • Fentanyl (236)
  • Heroin (120)
  • Oxycodone (69)
  • Marijuana (Cannabis) (68)
  • Synthetic Opioids (20)
  • Hydromorphone (13)
  • Ecstasy/MDMA (10)
  • Amphetamines (4)
  • Benzodiazepines (4)
  • Methadone (3)
  • LSD (2)
  • Morphine (2)
  • Steroids (2)
  • Barbiturates (1)
  • Marijuana Concentrates (1)
  • Peyote & Mescaline (1)
  • Psilocybin (1)
  • Opioids (16)

Field Division

  • Washington, DC (55)
  • Seattle (8)
  • San Francisco (6)
  • Dallas (5)
  • New England (5)
  • Sede (5)
  • Chicago (4)
  • Houston (4)
  • New York (3)
  • St. Louis (3)
  • New Jersey (2)
  • Detroit (1)
  • Rocky Mountain (1)
  • San Diego (1)
  • Miami (9)
  • Atlanta (7)
Clear All Results
PRESS RELEASE

Court Orders North Carolina Pharmacy to Pay $500,000 Penalty and Enters Injunction to Prevent Filling Illegal Controlled Substance Prescriptions

Diciembre 06, 2024
WASHINGTON – A federal court ordered an Elkin, North Carolina, pharmacy to pay a $500,000 penalty and enjoined the pharmacy and its pharmacists from dispensing controlled substances, including opioids, without taking steps to help ensure the drugs will not be abused or diverted. The consent decree resolves a complaint filed...
Diciembre 06, 2024
PRESS RELEASE

Doctor Convicted at Trial for Unlawfully Dispensing Controlled Substances

Enero 19, 2024
MIAMI – On January 12, a Miami federal court jury convicted a doctor of conspiracy to unlawfully dispense and distribute controlled substances, and six counts of unlawfully dispensing controlled substances. The conviction followed a seven-day trial before U.S. District Judge James I. Cohn. Under federal law, a physician is authorized...
Enero 19, 2024
PRESS RELEASE

Fourth Circuit Upholds Former Tabor City Doctor’s Conviction for Operating a Pill Mill

Junio 26, 2023
NEW BERN, N.C. – A three-judge panel from the Fourth Circuit Court of Appeals issued a unanimous, published opinion affirming former physician Jong Whan Kim’s conviction and sentence for operating a pill mill in Tabor City. The Fourth Circuit’s decision was the first published opinion by the Court upholding a...
Junio 26, 2023
PRESS RELEASE

Wilmington Doctor to Pay $170,000 to Resolve Allegations of Unlawful Prescribing of Opioids

Junio 23, 2023
WILMINGTON, N.C. – Dr. Mark S.T. Armitage, a physician practicing with Pelican Family Medicine in Wilmington, North Carolina, agreed to pay $170,000 to resolve alleged violations of the Controlled Substances Act. Dr. Armitage, who previously surrendered his Drug Enforcement Administration (DEA) registration to prescribe controlled substances, further agreed not to...
Junio 23, 2023
PRESS RELEASE

Panama City Physician Pays $225,000 to Settle Allegations that He Overprescribed Controlled Substances

Marzo 21, 2023
PENSACOLA, Fla. – Dr. George Barrio, a pain management physician who formerly practiced medicine at the NeuroMedical Institute in Panama City, agreed to pay $225,000 to resolve allegations that he unlawfully prescribed opioids and other controlled substances to patients. The settlement was announced by Jason R. Coody, United States Attorney...
Marzo 21, 2023
PRESS RELEASE

Federal Court Issues Temporary Restraining Order Prohibiting Tampa-Area Clinic from Distributing Opioids and Other Prescription Drugs

Octubre 18, 2022
WASHINGTON – A federal court issued a temporary restraining order prohibiting a Tampa-area clinic, its operators and a doctor from administering, dispensing or distributing any controlled substances, including issuing prescriptions for opioids, the Department of Justice announced. In a complaint filed on Oct. 11 and unsealed Oct. 14, the United...
Octubre 18, 2022
PRESS RELEASE

Justice Department Obtains Temporary Restraining Order to Prevent Tampa-Area Physician from Writing Opioid Prescriptions

Julio 29, 2022
WASHINGTON – A federal court issued a temporary restraining order prohibiting a Tampa-area physician from prescribing opioids and other controlled substances, the Department of Justice announced today. In a complaint filed on July 18, and unsealed yesterday, the United States alleges that Dr. Neelam Taneja Uppal unlawfully wrote opioid prescriptions...
Julio 29, 2022
PRESS RELEASE

Federal Court Orders Clinic to Close, Physician and Clinic Owners to Pay $600,000 for Alleged Unlawful Opioid Distribution

Julio 27, 2022
WASHINGTON – A federal court ordered a Tampa-area pain management clinic to close and directed the clinic’s owners and its former physician to collectively pay $600,000 in civil penalties pursuant to agreed resolutions in a case alleging violations of the Controlled Substances Act (CSA), the Justice Department announced today. In...
Julio 27, 2022
PRESS RELEASE

Pharmacist Found Guilty of Illegally Dispensing and Distributing Controlled Substances

Noviembre 10, 2021
ATLANTA - Thomas Ukoshovbera A. Gbenedio has been convicted by a federal jury of illegally dispensing and distributing controlled substances from his pharmacy. “Removing and ultimately eliminating healthcare providers who unlawfully dispense pharmaceutical products for non-medical reasons is an important part of DEA’s mission,” said Special Agent in Charge of...
Noviembre 10, 2021
PRESS RELEASE

Federal Court Orders Tampa Pharmacy to Close in Case Alleging Unlawful Opioid Distribution

Noviembre 01, 2021
MIAMI - A federal court in Florida ordered a Tampa-area pharmacy shut down and prohibited two of its employees from ever owning, managing or operating any business where controlled substances are dispensed. Pursuant to an agreed consent judgment and permanent injunction filed in U.S. District Court for the Middle District...
Noviembre 01, 2021
Showing 1 - 10 of 16 results

Paginación

  • Current page 1
  • Página 2
  • Siguiente página ›
  • Última página »
  • Quienes Somos
    • Sobre
    • Contáctenos
    • Museo DEA
  • Recursos
    • Ley de Libertad de Información (FOIA)
    • Publicaciones
    • Galerías Multimedia
    • Programa de Asistencia a Testigos para Víctimas
  • Políticas
    • Accesibilidad, Complementos y Política
    • Políticas Legales y Descargos de Responsabilidad
    • Antidiscriminación y Represalias Acto
    • Política de Privacidad
    • Política de Igualdad de Oportunidades en el Empleo del U.S. DOJ
    • USA.gov
    • Protección de Denunciantes
    • Your Rights as a Federal Employee

United States Drug Enforcement Administration

DEA.gov is an official site of the U.S. Department of Justice
Facebook X LinkedIn Instagram

DEA Contact Center

(202) 307-1000
Contact the Webmaster